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Abstract
This study investigated the effects of environmental toxicants on the immune
system of two pinniped species, grey seals (Halichoerus grypus) and hooded seals
(Cystophora cristata).

The toxicants included two perfluorinated compounds (PFC),

perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), compounds
commonly found in a wide variety of household consumer products, including
Scotchguard and Teflon. Although corporations such as 3M curtailed the use of these
chemicals in the past decade, concentrations of these chemicals are increasing in the
arctic aquatic ecosystem and have been measured in the tissues and blood of arctic
pinnipeds. However, the effects of these chemicals on the immune system are poorly
understood in marine mammals. The hypothesis was tested, “PFOA and PFOS are
equally immunotoxic in arctic pinniped species,” using the following specific aims, 1)
quantify and assess changes in mitogen-induced lymphocyte proliferation upon
increasing concentrations of PFOA and PFOS and 2) compare changes in lymphocyte
proliferation between two pinniped species. This was the first study to demonstrate the
immunotoxic effects of PFOA and PFOS in two pinniped species; however, the effects
were not always similar between the species. Importantly, the concentrations tested
represent the range found in the blood of free-ranging animals, suggesting that freeranging animals may be at risk for immunotoxic effects.

vii

Introduction
Perfluorinated compounds
The most widely studied PFCs are PFOA and PFOS, synthetic chemicals used to
make fluoropolymer compounds that are incorporated into trademarked products such
as Teflon and Scotchgard.

PFOA has specific properties such as fire and soil

resistance, as well as oil, stain, grease, and water repellency (Perfluorooctanoic Acid,
2012); PFOS is also water- and lipid-repellent (Emerging Contaminants, 2014). These
qualities make PFOA and PFOS ideal agents to create non-stick surfaces and
waterproof membranes, as well as for use as surfactants in paints and cleaning
products (Perfluorooctanoic Acid, 2012). The U.S. Environmental Protection Agency
(EPA) states that the routine use of consumer products that are made with Teflon does
not pose a health concern to individuals, but the major issue lies in the fact that PFOA
and PFOS are very persistent in both humans and the environment and demonstrate
the ability to stay in human and animal tissues for long periods of time
(Perfluorooctanoic Acid, 2012).

Following the release of this information, 3M, the

primary manufacturer of PFOS, voluntarily withdrew from PFOS production in 2002
(Emerging Contaminants, 2014).

PFCs in the arctic ecosystem
PFCs are prevalent in the arctic aquatic ecosystem and have been measured in
the tissues and blood of arctic marine mammals. For example, several studies have
demonstrated the presence of PFCs in the tissues of ringed seals and polar bears in
Greenland (Butt et al. 2010, Levin et al., Rigét et al. 2013). Perfluorooctanoic acid
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(PFOA) and perfluorooctanesulfonic acid (PFOS) are two common PFCs that have
recently been increasing in arctic marine mammals; however, the potential toxic effects
of these chemicals on the immune system are poorly understood.

This study

investigated the immunotoxic effects of PFOA and PFOS in two pinniped species, grey
seals (Halichoerus grypus) and hooded seals (Cystophora cristata).

PFC Exposure
PFCs can enter into the environment through “direct emissions” via the
production and disposal of fluorochemicals, or through precursor compounds that yield
PFCs upon degradation and serve as “indirect sources” (Butt et al. 2010). Similarly,
humans and animals can be directly exposed through ingestion of PFCs in food and
water or inhalation via long-range air transport of particulate matter containing PFCs, or
through the use of commercial products that eventually break down to PFCs (Emerging
Contaminants, 2014). In cases where PFCs are detected in human sera, dietary intake
is thought to be the major route of uptake. Contaminated water and soil are the main
points of exposure for wildlife, and result in elevated PFC levels in both wildlife and
humans (Corsini et al. 2014).

Immunotoxicity
The immune system is composed of many diverse organs and cells that have
specialized functions and work cooperatively to protect the host from potentially
pathogenic agents including viruses, bacteria, parasites, fungi, neoplastic and non-self
cells (Kuby 1997). Immunotoxicity refers to the “ability to detect, quantify, and interpret
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direct and indirect alterations of the immune system resulting from exposure to
pharmaceuticals, environmental and occupational pollutants, as well as study immune
alterations (stimulatory or suppressive) and their mechanisms and effects on
susceptibility or duration of infectious, allergic, or autoimmune disease” (Burleson and
Dean, 1995).

The PFC contaminant-induced immunotoxicity may put humans and

wildlife at risk for infection by various pathogens, potentially resulting in morbidity or
mortality.

Adverse effects of PFCs in animals
Numerous studies (Butt et al. 2010, Corsini et al. 2014, Levin et al., Rigét et al.
2013) have investigated the effects of PFCs in various species. Research has been
conducted to experimentally expose animals to PFOA and PFOS, with various effects
including hepatomegaly and hepatic peroxisome proliferation; tumors of the liver,
testicles, and pancreas; reproductive and developmental abnormalities including
reduced fetal weight, skeletal and cardiac malformations; neurotoxicity; and
immunotoxicity (Corsini et al. 2014). In studies that exposed mice to levels of PFOS
that are found in the general human population, results showed that antibody production
was affected, specifically in suppression of the antigen-specific IgM antibody response
(Corsini et al. 2014).

Studies in other wildlife species, including birds, turtles, and

lizards, have also demonstrated similar immune system effects (Corsini et al. 2014).
Taken, together, these data provide the “weight of evidence” that PFCs are toxic to the
immune system.
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Adverse effects of PFCs in humans
The effects of PFCs on humans have been mounting in, but results are
inconclusive and more research is necessary.

Potential adverse effects include

increased incidence of chronic diseases that have an inflammatory component, such as
diabetes, heart disease, and stroke (Corsini et al. 2014).

PFCs have also been

suggested to interfere with fatty acid metabolism that could serve as a risk factor for
metabolic disorders and cardiovascular disease (Corsini et al. 2014). Preliminary data
through in vitro experiments and field studies involving human populations in close
vicinity to PFC plants suggests that PFC exposure may be linked to immunosuppressive
effects. Some features of immunity that were affected involved decreased levels of
immunoglobulins A and E in females, increased antinuclear antibodies, reduced natural
killer cell activity, and reduction of pro-inflammatory cytokine (TNF-α) release. Children
with increased serum levels of PFCs may be less receptive to vaccines due to the
effects on the immune system’s antibody response (Corsini et al. 2014).

Study Rationale
This research project was designed to evaluate the effects of PFOA and PFOS
on the immune system, one measure of health, of two pinniped species, grey seals and
hooded seals, and to determine if the species tested in the study were equally sensitive
to these chemicals. Any modulation of the immune system may increase an individual’s
susceptibility to bacteria, viruses, fungi, or protozoal agents, resulting in morbidity or
mortality. As these chemicals can biomagnify and bioaccumulate in the arctic food
chain, the results from this research will contribute in evaluating the consequences of
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global pollution and determine how toxicants in the aquatic environments affect arctic
marine mammal health. Wildlife health agencies may able to use these data to make
scientifically based decisions on the creation of preventative or remedial strategies to
protect marine mammals.

Hypothesis and objectives
The hypothesis was tested, “PFOA and PFOS are equally immunotoxic in arctic
pinniped species,” using the following specific aims:
1. Quantify and assess changes in mitogen-induced lymphocyte proliferation upon
increasing concentrations of PFOA and PFOS,
2. Compare changes in lymphocyte proliferation between pinniped species.

Materials and Methods
Source of cells
The immune cells, including peripheral blood mononuclear cells (PBMC), lymph
node lymphocytes (LN), and spleen cells, were acquired by my research advisor, Dr.
Milton Levin, in collaboration with the Mystic Aquarium, Sea World, Danish colleagues
Rune Dietz and Christian Sonne (Aarhus University, Denmark), and Gordon Waring and
Andrea Bogomolni (US Northeast Fisheries Science Center).

These cells were

harvested and cryopreserved from grey seals and hooded seals under appropriate
federal permits and IACUC approval (University of Connecticut).
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Functional immune assay
The selected assay for the measurement of the immune response was the
mitogen induced lymphocyte proliferation assay, previously demonstrated for marine
mammals (Levin et. al, Levin et al. 2010, Levin et al. 2008)). Lymphocyte proliferation is
one measure of cell-mediated immunity, important in the generation of effector and
memory lymphocytes. Cells were exposed to different mitogens and chemicals, then
assessed for proliferation response. In this experiment, the mitogen concanavalin A
(ConA) was utilized to stimulate T lymphocytes.
Cryopreserved immune cells were thawed in a 37°C water bath, then transferred
to a conical tube with 45 mL complete Dulbecco’s Modified Eagle Medium (DMEM)
culture medium.

The cells were washed three times in complete DMEM at room

temperature (25°C) for 10 min at 1000 rpm. Cells were then re-suspended in complete
DMEM. A 50 µL aliquot was removed for counting on a hemocytometer, and the cell
solution volume was adjusted to achieve a working cell concentration of 2 x 106 cells/ml
in complete DMEM. The working solution was plated in triplicate into a 96-well flat
bottom microtiter plate. To each well, 100 µL of cells was added, along with 50 µL of
chemical at eight increasing concentrations for PFOA (0, 1, 3, 10, 30, 100, 300, and
1000 ppb) or seven increasing concentrations for PFOS (0, 1, 3, 10, 30, 100, and 300
ppb). These concentrations encompass the range of PFOA (0.2 - 3.1 ppb) and PFOS
(21.1 - 196.6 ppb) that has been measured in the serum of free ranging East Greenland
ringed seals (Pusa hispida), another arctic pinniped species (pers comm). For mitogenstimulated cells, 50 µL of the T cell mitogen ConA, at either one of two concentrations
(optimal, 1µg/ml; sub-optimal, 0.1µg/ml) was added to each well, and for the
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unstimulated (no mitogen, NM) cells, 50 µL of complete DMEM was added to each well.
Plates were incubated for 48 hr at 37°C, 5% CO2, followed by an additional 18 hr
incubation after the addition of 20 µL/well 5-bromo-2’-deoxyuridine (BrdU), a thymidine
analog. After incubation, the plate was centrifuged at room temperature for 10 min at
1000 rpm, the supernatant was dumped off, and the plate was allowed to air-dry
overnight.

Lymphocyte proliferation was detected with a monoclonal antibody and

colorimetric enzymatic reaction (Cell Proliferation ELISA BrdU (colorimetric), Roche
Diagnostics GmbH, Mannheim Germany) as per manufacturer’s instructions using an
ELISA plate reader (Multiskan EX v.1.0) at 450 nm with a reference wavelength of 690
nm.

Statistics
A repeated measure one-way analysis of variance (RM-ANOVA) with Dunnett’s
test was performed to compare the exposed cells to the unexposed cells using p<0.05
for statistical significance, as cells from the same individual were divided into several
treatment groups. Dose-response curves were generated in Microsoft Excel to visualize
the effects of the different concentrations to the unexposed control. Dose response
curves were compared between the two species to determine potential species
differences.
Although not part of the hypothesis, lymphocyte proliferation of immune cells
from three different compartments in the hooded seal, PBMCs, mesenteric lymph
nodes, and spleen, was examined to determine if T lymphocytes proliferated at similar
rates.

A RM-ANOVA with Bonferroni test was performed to compare lymphocyte

proliferation among the compartments. In addition, we assessed the effects of PFOA
7

and PFOS on lymphocytes isolated from lymph nodes.

Statistical analysis was

performed as per PBMC above. See Appendix A for results.

Results
PFOA and PFOS
Raw values of optical density for lymphocyte proliferation in grey seals and
hooded seals with PFOS or PFOA exposure are listed in Tables 1-6.
In vitro exposure of grey seal PBMC to PFOS did not significantly affect
lymphocyte proliferation (Figure 1). In vitro exposure of grey seal PBMC to PFOA
significantly increased lymphocyte proliferation at concentrations of 3, 10, 30, and 100
ppb in cells stimulated with opt-ConA mitogen (Figure 2).
In vitro exposure of hooded seal PBMC to PFOS significantly increased
lymphocyte proliferation at concentrations of 3, 10, 30, 100, and 300 ppb in
unstimulated cells, and concentrations of 3, 10, 30, and 100 ppb in cells stimulated with
opt-ConA and sub-ConA mitogen (Figure 3). In vitro exposure of hooded seal PBMC to
PFOA significantly increased lymphocyte proliferation at concentrations of 10, 30, and
100 ppb in unstimulated cells, and concentrations of 1, 3, 10, 30, and 100 ppb in cells
stimulated with opt-ConA and sub-ConA mitogen (Figure 4).

Discussion
This is the first study to demonstrate the immunotoxic effects of PFOA and PFOS
in grey seals and hooded seals. PFOA induced significant effects on grey seal PBMC
proliferation only at the optimal ConA concentration, but induced significant effects on
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hooded seal PBMC proliferation with both concentrations of ConA, as well as
unstimulated cells.

PFOS did not have significant effects on grey seal PBMC

proliferation; however, the power of the test was low, indicating that a larger sample size
is required in order to be confident in negative results. PFOS induced significant effects
on hooded seal PBMC proliferation with both concentrations of ConA, as well as
unstimulated cells.
Importantly, both PFOA and PFOS induced significant effects on the proliferation
of unstimulated hooded seal lymphocytes, indicating that PFOA and PFOS could induce
lymphocyte proliferation in the absence of mitogen, but only in hooded seals. It is also
important to note that in grey seal PBMC, PFOA induced significant effects only in
proliferation of lymphocytes that were stimulated with opt-ConA, which supports the use
of ConA at both optimal and sub-optimal concentrations. In the majority of cases of
significant effects on proliferation with sub-ConA, there were also significant effects with
opt-ConA; however the reverse was not always true. If only the sub-ConA mitogen was
used in trial, then we would fail to see significant effects. In future studies, both optConA and sub-ConA concentrations of mitogen should be used.

Immunotoxic risk in wild populations
The concentrations of PFOA and PFOS that were used in this in vitro study
encompass the range of PFOA (0.2 - 3.1 ppb) and PFOS (21.1 - 196.6 ppb) that has
been measured in vivo in the serum of free ranging ringed seals, an arctic pinniped
species similar to the hooded seals and grey seals included in this study. A comparison
between the range of either PFOA or PFOS concentrations found in free ranging
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pinnipeds and the in vitro concentrations is displayed in Figures 8-11, with the black
brackets indicating the range of PFC concentrations in free ranging animals. Although
lymphocyte proliferation has been determined to be statistically significant with in vitro
concentrations of PFOA or PFOS in this study, several in vitro concentrations tested fell
within the range of in vivo concentrations. Therefore, these data suggest that freeranging pinnipeds may be at risk for the modulation of lymphocyte proliferation induced
by PFOA and PFOS. Interestingly, for grey seal PBMCs, exposure to PFOS did not
induce any significant changes, even at concentrations observed in free-ranging
animals.
Further studies might involve measuring in vivo serum concentrations of PFOA
and PFOS and observing the correlation with corresponding measured optical densities
from the same samples to determine whether the in vitro results are accurately
representative of the in vivo data.

Conclusions
These data reject the hypothesis that PFOA and PFOS are equally immunotoxic
in the two pinniped species, grey seals and hooded seals, because the effects on
lymphocyte proliferation were not always similar between species. However, the data
does provide evidence to support the immunotoxicity of PFOA and PFOS in these
species.
Increased lymphocyte proliferation indicates an active immune response against
a potentially pathogenic antigen, but the consequences of this response are not fully
understood.

A modulated level of lymphocyte proliferation is an effective defense
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mechanism of the immune system, but uncontrolled proliferation of T cell lymphocytes
might lead to neoplastic growth and formation of tumors or lymphomas.
Further studies should be performed to examine B cell lymphocyte proliferation.
Uncontrolled proliferation of B cell lymphocytes could lead to overstimulation of the
adaptive immune response and might give rise to autoantibodies and subsequent
autoimmune disorders.

Appendix A
Comparison among hooded seal immune cells
Figure 7 shows hooded seal lymphocyte proliferation among cells of three
different immune compartments, including PBMC, lymph node, and spleen, without
exposure to PFOA or PFOS chemicals. Proliferation of PBMC vs. lymph node cells was
significantly different only when stimulated with sub-optimal ConA, but there were no
other significant differences between the compartments.

This study should be

expanded with a larger sample size for all three immune compartments in order to
strengthen the data and provide for further conclusions.

These preliminary data

suggest that cells from different immune compartments are not equally proliferative and
respond differently to stimulation by ConA mitogen.
In vitro exposure of hooded seal LN to PFOS significantly increased lymphocyte
proliferation at a PFOS concentration of 300 ppb in cells stimulated with opt-ConA and
sub-ConA mitogen (Figure 5).

In vitro exposure of hooded seal LN to PFOA

significantly increased lymphocyte proliferation at PFOA concentrations of 1, 3, 10, 30,
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and 100 ppb for cells stimulated with opt-ConA mitogen and concentrations of 3, 10, 30,
100, and 300 ppb for cells stimulated with sub-ConA mitogen (Figure 6).

Comparison of lymphocyte proliferation among hooded seal PBMC, LN, and spleen
Figure 7 compares lymphocyte proliferation among hooded seal PBMC, LN, and
spleen cells at 0 ppb concentration of PFOA chemical. This data has been analyzed
separately from the 0ppb concentration of PFOS data, to account for the varied
composition of the 0ppb control media (complete DMEM): the media in the PFOS
solution contains methanol, but the media in the PFOA solution does not contain
methanol.
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Table 1. Mitogen induced lymphocyte proliferation values (optical density) for grey
seals PBMC upon in vitro exposure to increasing concentrations of PFOS.

Table 2. Mitogen induced lymphocyte proliferation values (optical density) for grey
seals PBMC upon in vitro exposure to increasing concentrations of PFOA.
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Table 3. Mitogen induced lymphocyte proliferation values (optical density) for hooded
seals PBMC upon in vitro exposure to increasing concentrations of PFOS.

Table 4. Mitogen induced lymphocyte proliferation values (optical density) for hooded
seals PBMC upon in vitro exposure to increasing concentrations of PFOA.

14

Table 5. Mitogen induced lymphocyte proliferation values (optical density) for hooded
seals LN upon in vitro exposure to increasing concentrations of PFOS.

Table 6. Mitogen induced lymphocyte proliferation values (optical density) for hooded
seals LN upon in vitro exposure to increasing concentrations of PFOA.
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Figure 1. Effects of PFOS on lymphocyte proliferation in grey seal PBMC (n=5).
No significant findings.
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Figure 2. Effects of PFOA on lymphocyte proliferation in grey seal PBMC (n=4).
*, p<0.05 compared to 0 ppb.
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Figure 3. Effects of PFOS on lymphocyte proliferation in hooded seal PBMC (n=6).
*, p< 0.05 compared to 0 ppb.
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Figure 4. Effects of PFOA on lymphocyte proliferation in hooded seal PBMC (n=6).
*, p< 0.05 compared to 0 ppb.
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Figure 5. Effects of PFOS on lymphocyte proliferation in hooded seal LN (n=6).
*, p< 0.05 compared to 0 ppb.
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Figure 6. Effects of PFOA on lymphocyte proliferation in hooded seal LN (n=6).
*, p< 0.05 compared to 0 ppb.
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Figure 8. Comparison of the range of PFOA concentration found in free ranging
pinnipeds (black brackets) with in vitro hooded seal PBMC lymphocyte proliferation
under PFOA exposure. *, p< 0.05 compared to 0 ppb.
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Figure 9. Comparison of the range of PFOS concentration found in free ranging
pinnipeds (black brackets) with in vitro hooded seal PBMC lymphocyte proliferation
under PFOS exposure. *, p< 0.05 compared to 0 ppb.
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Figure 10. Comparison of the range of PFOA concentration found in free ranging
pinnipeds (black brackets) with in vitro grey seal PBMC lymphocyte proliferation
under PFOA exposure. *, p< 0.05 compared to 0 ppb.
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Figure 11. Comparison of the range of PFOS concentration found in free ranging
pinnipeds (black brackets) with in vitro grey seal PBMC lymphocyte proliferation
under PFOS exposure. *, p< 0.05 compared to 0 ppb.
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